HIV Antiretroviral Update: PSSNY AlbanyMed Conference
At the completion of the activity viewers will be able to:
State current guidelines for antiretroviral therapy for people with HIV regarding when to start, what to start, and when to switch.
Describe current treatment strategies for treatment-experienced people with HIV.
List recently approved and investigational antiretroviral agents.
Roy M. Gulick, MD, MPH
- Dr. Gulick is Rochelle Belfer Professor in Medicine and Chief of the Division of Infectious Diseases at Weill Cornell Medicine and Attending Physician at the New York Presbyterian Hospital in New York City. He is board certified in internal medicine and infectious diseases.
- Dr. Gulick’s research interests include designing, conducting and analyzing clinical trials to refine antiretroviral therapy strategies for HIV treatment and prevention and assess antiviral agents with new mechanisms of action. He currently serves as Principal Investigator of the Cornell-New Jersey HIV Clinical Trials Unit of the AIDS Clinical Trials Group (ACTG) and the HIV Prevention Trials Network (HPTN), sponsored by the U.S. National Institutes of Health.
- He also serves as the Co-Chair of the U.S. Department of Health and Human Services (DHHS) Panel on Clinical Practices for Treatment of HIV Infection and previously served as a Member and as Chair of the Antiviral Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) and as a Member and as Chair of the NIH Office of AIDS Research Advisory Committee (OARAC). He most recently serves as the Co-Chair of the NIH COVID-19 Treatment Guidelines Panel. He is a Member of the American Society of Clinical Investigation (ASCI), the Association of American Physicians (AAP), International AIDS Society (IAS), and the Infectious Diseases Society of America (IDSA), and has presented at national and international meetings and published widely.
ACPE UAN #
- 1.00 ACPEThe Arnold & Marie Schwartz College of Pharmacy and Health Sciences is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.